TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
ADCT

ADC Therapeutics SA

Healthcare · Biotechnology

1.10$ +1.0% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Balance Sheet

ADC Therapeutics SA (ADCT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 323 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ADCT
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
155 272 151 138 514 618 491 355 322 323
151 265 142 123 450 525 435 336 307 306
144 263 139 116 439 467 326 279 251 261
144 263 139 116 439 467 326 279 251 261
5.9 1.9 0.4 2.8 2.7 31 73 25 20 29
0.3 1.2 2.5 6.5 11 12 16 18 4.2
1.1 1.5 6.3 4.8 11 10.0
2.9 5.4 6.7 8.4 10 14 14
14 23 24 27 178 452 411 503 525 509
9.7 21 22 20 40 74 82 68 80 70
1.1 4.6 7.6 14 1.5 1.4 3.0
2.1 7.6 6.8 3.3 5.3 12 12 16 18 9.2
108 125 97 113 114 112
141 249 126 111 336 166 79 -148 -203 -186
-119 -209 -332 -449 -695 -925 -1,095 -1,335 -1,493 -1,636
59 54 67 65 77 78 82 97 127

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?